BGU:CA:TSX-Bristol Gate Concentrated US Equity ETF (CAD)

ETF | US Equity |

Last Closing

CAD 44.22

Change

0.00 (0.00)%

Market Cap

CAD 0.11B

Volume

1.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-23 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.11 (-0.08%)

CAD 15.25B
ZSP:CA BMO S&P 500

-0.34 (-0.41%)

CAD 15.01B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.02 (+0.03%)

CAD 10.19B
VUN:CA Vanguard US Total Market

-0.06 (-0.06%)

CAD 8.77B
XUS:CA iShares Core S&P 500 Index ETF

N/A

CAD 6.62B
HXS:CA Global X S&P 500® Index Corpo..

-0.02 (-0.03%)

CAD 3.80B
VSP:CA Vanguard S&P 500 CAD hedged

+0.02 (+0.02%)

CAD 3.31B
QUU:CA Mackenzie US Large Cap Equity ..

-0.37 (-0.17%)

CAD 3.07B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.06 (+0.04%)

CAD 3.01B
XUU:CA iShares Core S&P US Total Mark..

+0.07 (+0.13%)

CAD 2.92B

ETFs Containing BGU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.97% 39% F 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.97% 38% F 71% C-
Trailing 12 Months  
Capital Gain 27.29% 68% D+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.29% 68% D+ 82% B
Trailing 5 Years  
Capital Gain 74.71% 60% D- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.71% 55% F 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 11.37% 60% D- 78% C+
Dividend Return 11.37% 53% F 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.87% 72% C 65% D
Risk Adjusted Return 95.80% 71% C- 97% N/A
Market Capitalization 0.11B 31% F 39% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.